122 related articles for article (PubMed ID: 21617851)
1. Overexpression of EGR-1 modulates the activity of NF-κB and AP-1 in prostate carcinoma PC-3 and LNCaP cell lines.
Parra E; Ferreira J; Ortega A
Int J Oncol; 2011 Aug; 39(2):345-52. PubMed ID: 21617851
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is associated with decreased expression of AP-1 and NF-κB.
Parra E; Ferreira J; Saenz L
Int J Mol Med; 2011 Nov; 28(5):847-53. PubMed ID: 21743958
[TBL] [Abstract][Full Text] [Related]
3. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
Mukhopadhyay A; Bueso-Ramos C; Chatterjee D; Pantazis P; Aggarwal BB
Oncogene; 2001 Nov; 20(52):7597-609. PubMed ID: 11753638
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress enhances AP-1 and NF-κB-mediated regulation of β(2)-glycoprotein I gene expression in hepatoma cells.
Chiu WC; Chen CJ; Lee TS; Chen ZJ; Ke PH; Chiang AN
J Cell Biochem; 2010 Nov; 111(4):988-98. PubMed ID: 20665665
[TBL] [Abstract][Full Text] [Related]
5. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
8. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
[TBL] [Abstract][Full Text] [Related]
9. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
Uzzo RG; Crispen PL; Golovine K; Makhov P; Horwitz EM; Kolenko VM
Carcinogenesis; 2006 Oct; 27(10):1980-90. PubMed ID: 16606632
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.
Guseva NV; Taghiyev AF; Sturm MT; Rokhlin OW; Cohen MB
Mol Cancer Res; 2004 Oct; 2(10):574-84. PubMed ID: 15498932
[TBL] [Abstract][Full Text] [Related]
12. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
[TBL] [Abstract][Full Text] [Related]
13. Lead activates nuclear transcription factor-kappaB, activator protein-1, and amino-terminal c-Jun kinase in pheochromocytoma cells.
Ramesh GT; Manna SK; Aggarwal BB; Jadhav AL
Toxicol Appl Pharmacol; 1999 Mar; 155(3):280-6. PubMed ID: 10079214
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
15. Cancer chemopreventive activity of maslinic acid: suppression of COX-2 expression and inhibition of NF-κB and AP-1 activation in Raji cells.
Hsum YW; Yew WT; Hong PL; Soo KK; Hoon LS; Chieng YC; Mooi LY
Planta Med; 2011 Jan; 77(2):152-7. PubMed ID: 20669087
[TBL] [Abstract][Full Text] [Related]
16. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
[TBL] [Abstract][Full Text] [Related]
17. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
18. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
19. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]